drugset
Drugs / TheraCal PT
last change Nov 2025 re-read 2 minutes ago

TheraCal PT

also known as ThPT

Other / unclassified

Developed for
pulpitis
Investigated by
Ain Shams University · Cairo University

Trials 2 · a red edge is where a trial was stopped

today NCT04617600 · not/applicable NCT04167943 · Ph 3
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT04167943 Nov 2019 → Aug 2021 pulpitis Ain Shams University Completed No outcome recorded
Phase not applicable1 trial
— NCT04617600 Mar → Jun 2022 pulpitis Cairo University Unknown No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06880471 Comparator Dec 2024 → Oct 2025 pulpitis Cumhuriyet University Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as TheraCal PT “Evaluation of four vital pulp therapies for primary molars using a dual-cured tricalcium silicate (TheraCal PT): one-year results of a non-randomized clinical trial.” PMID 36890738 ↗ Mar 2023
2

NCT06880471 ↗

NCT04617600 ↗
Known as ThPT “TheraCal PT (ThPT, Bisco Inc)” NCT06880471 ↗
Modality Other / unclassified “TheraCAL PT, a dual cured tricalcium silicate cement will be used in all groups as the pulp capping material.” NCT04167943 ↗